Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
JMM Innovations
Massachusetts, United States
- Ownership
- Private
- Employees
- ~1
- Development stage
- Other
01
Overview
JMM Innovations, LLC is a strategic advisory and investment group founded by Dr. John Maraganore, former CEO of Alnylam, supporting the advancement of biomedical innovation to patients by providing strategic advice, board participation, and mentorship to biotechnology companies at various stages
- Industry
- Investors
02
Partnerships
AlnylamBeam TherapeuticsKymera TherapeuticsRapport TherapeuticsTakeda PharmaceuticalsAera TherapeuticsAitiaHemab TherapeuticsOrbital Therapeutics
Beyond the preview
Go deeper on JMM Innovations.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on JMM Innovations.